Table 2 A comparison of hematological parameters between CAD and controls
From: Genetic and clinical study of myeloperoxidase's association with coronary artery disease
Parameters | CAD (n = 70) | Control (n = 30) | P-value |
|---|---|---|---|
RBC (1012/l) | 5 ± 0.6 | 5.1 ± 0.63 | 0.6360 |
WBC (109/l) | 8.8 ± 2.8 | 8 ± 2.6 | 0.0806 |
GRAN (109/l) | 6 ± 2.3 | 6.9 ± 10.1 | 0.1166 |
LYM (109/l) | 2.4 ± 0.8 | 8.5 ± 14.1 | 0.9420 |
MID (109/l) | 0.6 ± 1.1 | 0.8 ± 1.3 | 0.5209 |
HB (g/dl) | 14.2 ± 1.8 | 14.1 ± 2.1 | 0.5732 |
HCT (%) | 42.3 ± 5.2 | 41.6 ± 9 | 0.7432 |
MCV (fl) | 84.7 ± 6.2 | 83.2 ± 7 | 0.1872 |
MCH (pg) | 28.4 ± 2.5 | 27.6 ± 2.8 | 0.1285 |
MCHC (g/dl) | 33.5 ± 1.2 | 33.1 ± 1.1 | 0.1832 |
RDW% (%) | 13.2 ± 1.5 | 13.7 ± 1.2 | 0.0396* |
RDWa (fl) | 56.4 ± 6.8 | 55.7 ± 10.4 | 0.4991 |
PLT (109/l) | 246.9 ± 66.8 | 245.5 ± 63.6 | 0.9597 |
PCT (%) | 0.2 ± 0.05 | 0.2 ± 0.05 | 0.7856 |
MPV (fl) | 8.2 ± 0.8 | 8.6 ± 0.9 | 0.0377* |
PDW (fl) | 11.8 ± 1.2 | 12.3 ± 1.5 | 0.0602 |
PLCR (%) | 17.9 ± 6 | 19.8 ± 6.6 | 0.0652 |